Psoriasis affects individuals of African descent and white Brazilians similarly C. Porto Ferreira, C.J. Martins, P.R. Issa, R. de Vasconcellos Carvalhaes de Oliveira, A.M. Da-Cruz

Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study A. Martorell-Calatayud, S. Santos-Alarcón, A. Sahuquillo-Torralba, R. Rivera-Díaz, I. Belinchón-Romero, D. Ruiz-Genao, A. Romero-Maté, R. Ruiz-Villaverde, M. Ferran-Farrés, F. Gallardo-Hernández, M. Almenara-Blasco, J.A. Suarez-Perez, Á. González-Cantero, E. Martínez-Lorenzo, J.M. Fernández-Armenteros, E. del Alcázar-Viladomiu, J. García-Latasa, V. Rocamora-Durant, M. Ara-Martín, A. Mateu-Puchades, M. Llamas-Velasco, E. Vilarrasa, M. Velasco-Pastor, P. De la Cueva, J.M. Carrascosa, J. Magdaleno-Tapial

Psoriasis Severity, Health-Related Quality of Life, Work Productivity, and Activity Impairments Among Patients With Moderate to Severe Psoriasis Receiving Systemic Treatment: Real-World Data From Clinical Practice in Spain E. Daudén, D. Vidal, A. Romero, M.T. Bordel, R. Rivera, J. Márquez, E. Zamora, L. Martinez, M.J. Ocaña, C. Vila, P. Iribarren, N. Corona, A. Zulaica